Work

MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients

Year: 2020

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-020-05653-y

Authors: Brian G. Hunt, Christina A. Wicker, Jennifer R. Bourn, Elyse E. Lower, Vinita Takiar, Susan E. Waltz

Institutions: University of Cincinnati, Cincinnati VA Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, Cancer Institute, University of Cincinnati, National Cancer Institute

Awards: G3375772211, G3941954995, Targeting glycolytic metabolism in RON-driven breast cancer, G5173757561, G5411901319, G7303595192

OpenAlex ID: W3017965384

FWCI: 0.791

Cites: 47

Cited by: 21

Related to: 10